Activation of kinase pathways in MCF-7 cells by 17β-estradiol and structurally diverse estrogenic compounds

Journal of Steroid Biochemistry and Molecular Biology

Volumn 98, Issue 2-3, 2006, Pages 122-132

  Li, Xiangrong ^a   Zhang, Shu ^a   Safe, Stephen ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Kinases; MCF 7 cells; Non genomic; Xenoestrogens

Indexed keywords

2',3',4',5' TETRACHLORO 4 BIPHENYLOL; 2,2(4 HYDROXYPHENYL) 1,1,1 TRICHLOROETHANE; 4,4' ISOPROPYLIDENEDIPHENOL; BENZENE DERIVATIVE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE 4; CHLORDECONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIETHYLSTILBESTROL; ENDOSULFAN; ESTRADIOL; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; NONYLPHENOL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; RESVERATROL; TRICHLOROETHANE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION; TRANSACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL PROLIFERATION; CHLORDECONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIETHYLSTILBESTROL; DOSE-RESPONSE RELATIONSHIP, DRUG; EIF-2 KINASE; ENDOSULFAN; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHENOLS; SIGNAL TRANSDUCTION; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 31544438854     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.08.018     Document Type: Article

References (61)

1. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R.M. Evans The nuclear receptor superfamily: the second decade Cell 83 1995 835 839
2. L. Altucci, and H. Gronemeyer Nuclear receptors in cell life and death Trends Endocrinol. Metab. 12 2001 460 468
3. S. Nilsson, and J.A. Gustafsson Biological role of estrogen and estrogen receptors Crit. Rev. Biochem. Mol. Biol. 37 2002 1 28
4. J.M. Olefsky Nuclear receptor minireview series J. Biol. Chem. 276 2001 36863 36864
5. J.M. Hall, J.F. Couse, and K.S. Korach The multifaceted mechanisms of estradiol and estrogen receptor signaling J. Biol. Chem. 276 2001 36869 36872
6. M.G. Rosenfeld, and C.K. Glass Coregulator codes of transcriptional regulation by nuclear receptors J. Biol. Chem. 276 2001 36865 36868
7. N.J. McKenna, and B.W. O'Malley Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 2002 465 474
8. O. Hermanson, C.K. Glass, and M.G. Rosenfeld Nuclear receptor coregulators: multiple modes of modification Trends Endocrinol. Metab. 13 2002 55 60
9. C.L. Smith, and B.W. O'Malley Coregulator function: a key to understanding tissue specificity of selected receptor modulators Endocrine Rev. 25 2004 45 71
10. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Häggblad, S. Nilsson, and J.A. Gustafsson Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors-α and -β Endocrinology 138 1997 863 870
11. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S. Safe, P.T. Van der Saag, B. Van der Burg, and J.-Å. Gustafsson Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor-β Endocrinology 139 1998 4252 4263
12. D.S. Hunter, L.C. Hodges, P.M. Vonier, R. Fuchs-Young, M.M. Gottardis, and C.L. Walker Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium Cancer Res. 59 1999 3090 3099
13. K. Paech, P. Webb, G.G. Kuiper, S. Nilsson, J. Gustafsson, P.J. Kushner, and T.S. Scanlan Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites Science 277 1997 1508 1510
14. M. Jakacka, M. Ito, J. Weiss, P.-Y. Chien, B.D. Gehm, and J.L. Jameson Estrogen receptor binding to DNA is not required for its activity through the non-classical AP1 pathway J. Biol. Chem. 276 2001 13615 13621
15. M. Razandi, A. Pedram, G.L. Greene, and E.R. Levin Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells Mol. Endocrinol. 13 1999 307 319
16. C.S. Watson, B. Gametchu, A.M. Norfleet, C.H. Campbel, and M.L. Thomas Rapid, non-genomic actions of estrogens Women Cancer 1 1998 21 28
17. E.R. Levin Cellular functions of plasma membrane estrogen receptors Steroids 67 2002 471 475
18. C.S. Watson, C.H. Campbell, and B. Gametchu The dynamic and elusive membrane estrogen receptor-α Steroids 67 2002 429 437
19. A. Nadal, P. onso-Magdalena, C. Ripoll, and E. Fuentes Disentangling the molecular mechanisms of action of endogenous and environmental estrogens Pflugers Arch. 2004
20. J.H. Segars, and P.H. Driggers Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes Trends Endocrinol. Metab. 13 2002 349 354
21. N.N. Bulayeva, and C.S. Watson Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways Environ. Health Perspect. 112 2004 1481 1487
22. M. Maggiolini, A. Vivacqua, G. Fasanella, A.G. Recchia, D. Sisci, V. Pezzi, D. Montanaro, A.M. Musti, D. Picard, and S. Ando The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells J. Biol. Chem. 279 2004 27008 27016
23. E.J. Filardo, J.A. Quinn, K.I. Bland, and A.R. Frackelton Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Mol. Endocrinol. 14 2000 1649 1660
24. E.J. Filardo, J.A. Quinn, A.R.J. Frackelton, and K.I. Bland Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis Mol. Endocrinol. 16 2002 70 84
25. G. Castoria, M.V. Barone, M. Di Domenico, A. Bilancio, D. Ametrano, A. Migliaccio, and F. Auricchio Non-transcriptional action of oestradiol and progestin triggers DNA synthesis EMBO J. 18 1999 2500 2510
26. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells EMBO J. 15 1996 1292 1300
27. ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor EMBO J. 17 1998 2008 2018
28. A. Migliaccio, G. Castoria, M. Di Domenico, A. de Falco, A. Bilancio, M. Lombardi, M.V. Barone, D. Ametrano, M.S. Zannini, C. Abbondanza, and F. Auricchio Steroid-induced androgen receptor-oestradiol receptor-β-Src complex triggers prostate cancer cell proliferation EMBO J. 19 2000 5406 5417
29. T. Improta-Brears, A.R. Whorton, F. Codazzi, J.D. York, T. Meyer, and D.P. McDonnell Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium Proc. Natl. Acad. Sci. U.S.A. 96 1999 4686 4691
30. R. Duan, W. Xie, R. Burghardt, and S. Safe Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1 J. Biol. Chem. 276 2001 11590 11598
31. G. Castoria, A. Migliaccio, A. Bilancio, M. Di Domenico, A. de Falco, M. Lombardi, R. Fiorentino, L. Varricchio, M.V. Barone, and F. Auricchio PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells EMBO J. 20 2001 6050 6059
32. X. Li, C. Qin, R. Burghardt, and S. Safe Hormonal regulation of lactate dehydrogenase-A through activation of protein kinase C pathways in MCF-7 breast cancer cells Biochem. Biophys. Res. Commun. 320 2004 625 634
33. C. Qin, I. Samudio, S. Ngwenya, and S. Safe Estrogen-dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP-dependent pathways Mol. Carcinog. 40 2004 160 170
34. L. Dong, W. Wang, F. Wang, M. Stoner, J.C. Reed, M. Harigai, M. Kladde, C. Vyhlidal, and S. Safe Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells J. Biol. Chem. 174 1999 32099 32107
35. E. Castro-Rivera, I. Samudio, and S. Safe Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements J. Biol. Chem. 276 2001 30853 30861
36. R. Duan, W. Xie, X. Li, A. McDougal, and S. Safe Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells Biochem. Biophys. Res. Commun. 294 2002 384 394
37. C.C. Chen, W.R. Lee, and S. Safe Egr-1 is activated by 17β-estradiol in MCF-7 cells by mitogen-activated protein kinase-dependent phosphorylation of ELK-1 J. Cell Biochem. 93 2004 1063 1074
38. C. Qin, T. Nguyen, J. Stewart, I. Samudio, R. Burghardt, and S. Safe Estrogen upregulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of an NFκB/CTF-1 complex Mol. Endocrinol. 16 2002 1793 1809
39. A.M. Soto, C. Sonnenschein, K.L. Chung, M.F. Fernandez, N. Olea, and F.O. Serrano The E-screen assay as a tool to identify estrogens - an update on estrogenic environmental pollutants Environ. Health Persp. 103 1995 113 122
40. B.D. Gehm, J.M. McAndrews, P.-Y. Chien, and J.L. Jameson Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor Proc. Natl. Acad. Sci. U.S.A. 94 1997 14138 14143
41. C. Sonnenschein, and A.M. Soto An updated review of environmental estrogen and androgen mimics and antagonists J. Steroid Biochem. Mol. Biol. 65 1998 143 150
42. Å. Bergman, E. Klasson-Wehler, and H. Kuroki Selective retention of hydroxylated PCB metabolites in blood Environ. Health Persp. 102 1994 464 469
43. M. Moore, M. Mustain, K. Daniel, S. Safe, T. Zacharewski, B. Gillesby, A. Joyeux, and P. Balaguer Antiestrogenicity activity of hydroxylated PCBs identified in human serum Toxicol. Appl. Pharmacol. 142 1997 160 168
44. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
45. J.C. Gould, L.S. Leonard, S.C. Maness, B.L. Wagner, K. Connor, T. Zacharewski, S. Safe, D.P. McDonnell, and K.W. Gaido Bisphenol A interacts with the estrogen receptor-α in a distinct manner from estradiol Mol. Cell. Endocrinol. 142 1998 203 214
46. K. Yoon, L. Pallaroni, K. Ramamoorthy, K. Gaido, and S. Safe Ligand structure-dependent differences in activation of estrogen receptor-α in human HepG2 liver and U2 osteogenic cancer cell lines Mol. Cell. Endocrinol. 162 2000 211 220
47. K. Yoon, L. Pallaroni, M. Stoner, K. Gaido, and S. Safe Differential activation of wild-type and variant forms of estrogen receptor-α by synthetic and natural estrogenic compounds using a promoter containing three tandem estrogen-responsive elements J. Ster. Biochem. Mol. Biol. 78 2001 25 32
48. S. Oesterreich, P. Zhang, R.L. Guler, X. Sun, E.M. Curran, W.V. Welshons, C.K. Osborne, and A.V. Lee Re-expression of estrogen receptor-α in estrogen receptor-α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth Cancer Res. 61 2001 5771 5777
49. A.M. Gaben, C. Saucier, M. Bedin, G. Redeuilh, and J. Mester Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase Mol. Endocrinol. 18 2004 2700 2713
50. D.P. McDonnell The molecular pharmacology of SERMs TEM 10 1999 301 311
51. V.C. Jordan Targeted antiestrogens to prevent breast cancer Trends Endocrinol. Metab. 10 1999 312 317
52. C.L. Smith, and B.W. O'Malley Evolving concepts of selective estrogen receptor action: from basic science to clinical applications Trends Endocrinol. Metab. 10 1999 299 300
53. S.A. Fuqua, J. Russo, S.E. Shackney, and M.E. Stearns Estrogen, estrogen receptors and selective estrogen receptor modulators in human breast cancer J. Women's Cancer 2 2000 21 32
54. M.T. Tzukerman, A. Esty, D. Santiso-Mere, P. Danielian, M.G. Parker, R.G. Stein, J.W. Pike, and D.P. McDonnell Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions Mol. Endocrinol. 8 1994 21 30
55. D.P. McDonnell, D.L. Clemm, T. Hermann, M.E. Goldman, and J.W. Pike Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens Mol. Endocrinol. 9 1995 659 669
56. K.W. Gaido, L.S. Leonard, S.C. Maness, J.M. Galluzzo, D.P. McDonnell, B. Saville, and S. Safe Differential interaction of the methoxychlor metabolite HPTE with estrogen receptors alpha and beta Endocrinology 140 1999 5746 5753
57. K.W. Gaido, S.C. Maness, D.P. McDonnell, S.S. Dehal, D. Kupfer, and S. Safe Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies Mol. Pharmacol. 58 2000 852 858
58. R.Q. Lu, and G. Serrero Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells J. Cell. Physiol. 179 1999 297 304
59. O.P. Mgbonyebi, J. Russo, and I.H. Russo Antiproliferative effect of synthetic resveratrol on human breast epithelial cells Int. J. Oncol. 12 1998 865 869
60. R.T. Turner, G.L. Evans, M. Zhang, A. Maran, and J.C. Sibonga Is resveratrol an estrogen agonist in growing rats? Endocrinology 140 1999 50 54
61. C.M. Klinge, K.A. Blankenship, K.E. Risinger, S. Bhatnagar, E.L. Noisin, W.K. Sumanasekera, L. Zhao, D.M. Brey, and R.S. Keynton Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors-α and -β in endothelial cells J. Biol. Chem. 280 2005 7460 7468